Idioma:

Retinal imaging in Alzheimer's and neurodegenerative diseases

Snyder, Peter J. ; Alber, Jessica ; Alt, Clemens ; Bain, Lisa J. ; Bouma, Brett E. ; Bouwman, Femke H. ; DeBuc, Delia Cabrera ; Campbell, Melanie C.W. ; Carrillo, Maria C. ; Chew, Emily Y. ; Cordeiro, M. Francesca ; Dueñas, Michael R. ; Fernández, Brian M. ; Koronyo‐Hamaoui, Maya ; La Morgia, Chiara ; Carare, Roxana O’ ; Sadda, Srinivas R. ; Wijngaarden, Peter ; Snyder, Heather M.

Alzheimer's & dementia, 2021-01, Vol.17 (1), p.103-111 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por

Enviar para

Título:
Retinal imaging in Alzheimer's and neurodegenerative diseases
Autor: Snyder, Peter J. ; Alber, Jessica ; Alt, Clemens ; Bain, Lisa J. ; Bouma, Brett E. ; Bouwman, Femke H. ; DeBuc, Delia Cabrera ; Campbell, Melanie C.W. ; Carrillo, Maria C. ; Chew, Emily Y. ; Cordeiro, M. Francesca ; Dueñas, Michael R. ; Fernández, Brian M. ; Koronyo‐Hamaoui, Maya ; La Morgia, Chiara ; Carare, Roxana O’ ; Sadda, Srinivas R. ; Wijngaarden, Peter ; Snyder, Heather M.
Assuntos: Aged ; Aged, 80 and over ; Alzheimer Disease - diagnostic imaging ; Alzheimer's disease ; Biomarkers ; Brain - diagnostic imaging ; early detection ; eye ; Humans ; Middle Aged ; neurodegeneration ; Neurodegenerative Diseases - diagnostic imaging ; retina ; Retina - diagnostic imaging ; retinal imaging
É parte de: Alzheimer's & dementia, 2021-01, Vol.17 (1), p.103-111
Notas: Correction added on November 15, 2020, after first online publication: In the initial publication of this article, the affiliation for Michael R. Dueñas incorrectly indicated that he is retired. Affiliation 11 has been corrected to read: “Chief Public Health Officer, American Optometric Association, Washington, D.C.”
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-2
Descrição: In the last 20 years, research focused on developing retinal imaging as a source of potential biomarkers for Alzheimer's disease and other neurodegenerative diseases, has increased significantly. The Alzheimer's Association and the Alzheimer's & Dementia: Diagnosis, Assessment, Disease Monitoring editorial team (companion journal to Alzheimer's & Dementia) convened an interdisciplinary discussion in 2019 to identify a path to expedite the development of retinal biomarkers capable of identifying biological changes associated with AD, and for tracking progression of disease severity over time. As different retinal imaging modalities provide different types of structural and/or functional information, the discussion reflected on these modalities and their respective strengths and weaknesses. Discussion further focused on the importance of defining the context of use to help guide the development of retinal biomarkers. Moving from research to context of use, and ultimately to clinical evaluation, this article outlines ongoing retinal imaging research today in Alzheimer's and other brain diseases, including a discussion of future directions for this area of study.
Editor: United States
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 4 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Retinal imaging in Alzheimer's and neurodegenerative diseases

United States

Buscando em bases de dados remotas. Favor aguardar.